Abstract
In contrast to the vasculature of many other organs in the body, the uterine vasculature is very dynamic and is continuously undergoing significant vascular changes and remodeling. The uterus is exposed to a constantly changing hormonal milieu associated with fluctuations in estrogen and progesterone levels. The observed hemodynamic changes are mediated by alterations in numerous endogenous hormonal substances that are produced locally in the endothelium, vascular smooth muscle, and surrounding uterine tissues. These modulators includeboth vasodilators, such as nitric oxide (NO) and prostaglandins, and vasoconstrictors, such as endothe1in-1, throboxane A2, and prostaglandin F2α (PGF2α). In females, this modulation occurs throughout, life including the menstrual cycle, pregnancy, and finally during menopause. In the present chapter we will concentrate mainly on NO as a regulator of uterine and uteroplacental hemodynamics in the pregnant and nonpregnant states. Additionally we will discuss the role of NO in regulating umbilical blood flow, myometrial activity of the uterus, and hemo dynamic changes during menopause.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adamson SL, Myatt L, & Byrne BMP. 1998. Regulation of umbilical blood flow. In: Polin RA, Fox WW, eds. Fetal and Neonatal Physiology. 2nd ed. Philadelphia: WB Saunders, pp 977–988.
Bansal RK, Goldsmith PC, He Y, Zaloudek CT, Ecker JL, & Reimer RK. 1997. A decline in myometrial nitric oxide synthase expression is associated with labor and delivery. J Clin Invest 99:2502–2508.
Brody MJ, Clark KE, Edvinsson L, Owman CL, & Sjoberg NO. 1974. Determination of uterine blood volume and correlation with ovarian function. Proc Soc Exp Biol Med 147:91–96.
Buhimschi I, Yallampalli C, Dong YL, & Garfield RE. 1995. Involvement of a nitric oxide-cyclic guanosine monophosphate pathway in control of human uterine contractility during pregnancy. Am J Obstet Gynecol 172:1577–1584.
Buhimschi I, Ali M, Jain V, Chwalisz K, & Garfield RE. 1996. Differential regulation of nitric oxide in the rat uterus and cervix during pregnancy and labour. Hum Reprod 11:1755–1766.
Buhimschi C, Buhimschi I, Yallampalli C, Chwalisz K, & Garfield RE. 1997. Contrasting effects of diethyleneriamine-nitric oxide, a spontaneously releasing nitric oxide donor, on pregnant rat uterine contractility in vitro versus in vivo. Am J Obstet Gynecol 177:690–701.
Carpenter L, Baker RS, Greenberg SG, & Clark KE. 1997. Adenosine-induced uterine va-sodilation is mediated in part by nitric oxide. J Soc Gynecol Invest 4(1S):251A.
Clark KE, Baker RS, & Kopernik G. 1998. Ethinyl-estradiol induced increases in uterine blood flow are not mediated by nitric oxide. J Soc Gynecol Invest 5(1S): 145A.
Colburn P, & Buonassesse V. 1978. Estrogen-binding sites in endothelial cell cultures. Science 201:817.
Conrad KP, Joffe GM, Kruszyna H, Kruszyna R, Rochelle LG, Smith RP, Chavez JE, & Mosher MD. 1993. Identification of increased nitric oxide biosynthesis during pregnancy in rats. FASEB J 7:566–571.
Dainty IA, McGrath JC, Spedding M, & Templeton AGB. 1990. The influence of the initial stretch and the agonist-induced tone on the effect of basal and stimulated release of EDRF. Br J Pharmacol 100:161–113.
Davidge ST, Stranko CP, & Roberts JM. 1996. Urine but not plasma nitric oxide metabo lites are decreased in women with preeclampsia. Am J Obstet Gynecol 174:1008–1013.
De Nucci G, Thomas R, D’Orleans-Juste P, Antures E, Walder C, Warner TD, & Vane JR. 1988. Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci USA 85:9797–9800.
Diket AL, Pierce MR, Munshi UK, et al. 1994. Nitric oxide inhibition causes intrauterine growth retardation and hind-limb disruptions in rats. Am J Obstet Gynecol 177:1243–1250.
Eis ALW, Brockman DE, & Myatt L. 1997. Immunolocalization of the inducible nitric oxide synthase isoform in human feta1 membranes. Am J Reprod Immunol 38:289–294.
Erskine RLA, & Ritchie JWK. 1985. Umbilical artery blood flow characteristics in normal and growth-retarded fetuses. Br J Obstet Gynaecol 92:605–610.
Figueroa JP, Zhang J, Massmann GA, & Mirable CP. 1998. Differential regulation by estrogen of type I and type III nitric oxide synthase (NOS) mRNA expression in the uterus of non pregnant sheep. J Soc Gynecol Invest 5 (1S):182A.
Giles WB, Trudinger BJ, & Baird PJ. 1985. Fetal ambilical artery flow velocity waveforms and placental resistance: pathological correlation. Br J Obstet Gynaecol 92:31–38.
Giles W, O’Callaghan S, Boura A, & Walters W. 1992. Reduction in human fetal umbilical-placental vascular resistance by glyceryl trimirate. Lancet 340:856.
Grunewald C, Kublickas M, Carlstrom K, Lunell NO, & Nisell H. 1995. Effects of nitro-glycerin on the uterine and umbilical circulation in severe preeclampsia. Obstet Gynecol 86:600–604.
Hendricks SK, Ross B, Colverd MA, Cahill A, Shy K, & Benedetti TJ. 1992. Amylnitrite: use as a smooth muscle relaxant in difficult preterai cesarean section. Am J Perinatol 9:289–292.
Heymann MA, Bookstaylor B, Roman C, et al. 1993. Glyceryl trinitrate stops active labor in sheep. In: Moncada S, Feelish M, Busse R, Higgs EA, eds. The Biology of Nitric Oxide. London and Chapel Hill, NC: Portland Press, pp 201–203.
Huang J, Roby KF, Pace JL, Russell SW, & Hunt JS. 1995. Cellular localization and hormonal regulation of inducible nitric oxide synthase in cycling mouse uterus. J Leukocyte Biol 57:27–35.
Iafrati MD, Karas RH, Aronovitz M, Kim S, Sullivan TR, Lubahn DB, O’Donnell TF, Korach KS, & Mendelsohn ME. 1997. Estrogen inhibits the vascular injury response in estrogen receptor a deficient mice. Nature Med 3:545–548.
Ignarro LJ. 1989. Endothelium-derived nitric oxide: actions and properties. FASEB J 3:31–36.
Izumi H, & Garfield RE. 1995. Relaxant effects of nitric oxide and cyclic GMP on preg nant rat uterine longitudinal smooth muscle. Eur J Obstet Gynecol Reprod Biol 60:171–180.
Jaekle RK, Lutz PD, Rosenn B, Siddiqi TA, & Myatt L. 1994. Nitric oxide metabolites and preterai pregnancy complications. Am J Obstet Gynecol 171.1115–1119.
Jennings RW, MacGillivray TE, & Harrison MR. 1993. Nitric oxide inhibits preterai labor in the rhesus monkey. J Matern Fet Med 2:170–174.
Jones GD, & Poston L. 1996. The influence of modulations of nitric oxide synthesis on spontaneous human myometrial contractility in vitro. J Soc Gynecol Invest 3:346A.
Karas RH, Patterson BL, & Mendelsohn ME. 1994. Human vascular smooth muscle cells contain functional estrogen receptor. Circulation 89:1943–1950.
Kato S, Fomin VF, Lau K, & Ward RA. 1995. Effect of basic amino acids and alkaline pH on uterine contractility in vitro. J Soc Gynecol Invest 2:179.
Krebs C, Macara LM, Leiser R, Bowman AW, Greer IA, & Kingdom JCP. 1996. Intrauter-ine growth restriction with absent end-diastolic flow velocity in the umbilical artery is associated with maldevelopment of the placental terminal villous tree. Am J Obstet Gynecol 175:1534–1542.
Kuiper GGJM, Enmark E, Pelto-Huikko M, Nilsson S, & Gustafsson JA. 1996. Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 93:5925–5930.
Kuiper GGJM, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S, & Gustafsson JA. 1997. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β. Endocrinology 138:863–870.
Lang U, Baker RS, & Clark KE. 1997. Estrogen-induced increases in coronary blood flow are antagonized by inhibitors of nitric oxide synthesis. Eur J Obstet Gynecol 74:229–235.
Learmont JG, & Poston L. 1996. Nitric oxide is involved in flow-induced dilation of isolated human small fetoplacental arteries. Am J Obstet Gynecol 174:583–588.
Lees C, Campbell S, Jauniaux E, et al. 1993. Arrest of preterai labor and prolongation of gestation with glyceryl trinitrate, a nitric oxide donor. Lancet 343:1325–1326.
Lewin DJ. 1997. Researchers get down to the alphas and betas of estrogen’s effects. J NIH Res 9:23–25.
Lin AL, McGill HC, & Shain SA. 1982. Hormone receptors of the baboon cardiovascular system: biochemical characterization of aortic and myocardial cytoplasmic progesterone receptors. Circ Res 50:610–616.
Losordo DW, Kearney M, Kim EA, Jekanowski J, & Isner JM. 1994. Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of pre-menopausal women. Circulation 89:1501–1510.
Lyall F, Young A, & Greer IA. 1995. Nitric oxide concentrations are increased in the feto-placental circulation in pre-enclampsia. Am J Obstet Gynecol 173:714–718.
Lyall F, Greer IA, Young A, & Myatt L. 1996. Nitric oxide concentrations are increased in the fetoplacental circulation in intrauterine growth restriction. Placenta 17:165–168.
Magness RR, Phernetton TM, Shaw CE, & Long RA. 1998. Effect of estrogen treatment and pregnancy on ovine coronary vascular resistance and coronary artery endothelial nitric oxide synthase expression. J Soc Gynecol Invest 5 (1S):61A.
Makino Y, Izumi H, Makino I, & Shirakawa K. 1997. The effect of nitric oxide on uterine and umbilical artery flow velocity waveform in preeclampsia. Eur J Obstet Gynecol Re-prod Biol 73:139–143.
McGill H. 1989. Sex steroid hormone receptors in the cardiovascular system. Postgrad Med 85:64–68.
Molnar M, Suto T, Toth T, & Hertelendy F. 1994. Prolonged blockade of nitric oxide synthesis in gravid rats produces sustained hypertension, proteinuria, thrombocytopenia and intrauterine growth retardation. Am J Obstet Gynecol 170:1458–1466.
Moore PK, Al-Swayeh OA, Chong NWS, Evans RA, & Gibson A. 1990.1-N G-nitro argi-nine (l-NOARG) a novel, /-arginine-reversible inhibitor of endothelium-dependent vasodilatation in vitro. Br J Pharmacol 99:408–412.
Morey AK, Pedram A, Razandi M, Prins BA, Hu RM, Biesiada E, & Levin ER. 1997. Estrogen and progesterone inhibit vascular smooth muscle proliferation. Endocrinology 138:3330–3339.
Myatt L. 1992. Control of vascular resistance in the human placenta. Placenta 13: 329–341.
Myatt L, Brewer A, & Brockman DE. 1991. The action of nitric oxide in the perfused human fetal-placental circulation. Am J Obstet Gynecol 764:687–692.
Myatt L, Brewer AS, Langdon G, & Brockman DE. 1992. Attenuation of the vasoconstrictor effects of thromboxane and endothelin in the human fetal-placental circulation. Am J Obstet Gynecol 166:224–230.
Myatt L, Rosenfield RB, Eis AL, Brockman DE, Greer IA, & Lyall F. 1996. Nitrotyrosine residues in placenta. Evidence of peroxynitrite formation and action. Hypertension 28:488–493.
Myatt L, Eis Al, Brockman DE, Greer IA, & Lyall F. 1997. Endothelial nitric oxide synthase in placental villous tissue from normal, pre-eclamptic and intrauterine growth-restricted pregnancies. Hum Reprod 72:167–172.
Nakaya Y, Yamamoto S, Hamada Y, Kamada M, Aono T, & Niwa M. 1996. Inducible nitric oxide synthase in uterine smooth muscle. Life Sci 58:249–255.
Natuzzi ES, Ursell PC, Harrison M, Buscher C, & Riemer RK. 1993. Nitric oxide synthase activity in the pregnant uterus decreases at parturition. Biochem Biophys Res Common 194:1–8.
Neugarten J, Ding Q, Friedman A, Lei J, & Silbiger S. 1997. Sex hormones and renal nitric oxide synthetase. J Am Soc Nephrol 8:1240–1246.
Palmer RMJ, Ashton DS, & Moncada S. 1988. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 333:664–666.
Peng ATC, Garman RS, Shulman SM, DeMarchis E, Nyunt K, & Blancato LS. 1989. Intravenous nitroglycerin for uterine relaxation in the postpartum patient with retained placenta. Anesthesiology 71:172–175.
Ramsay B, Sooranna SR, & Johnson MR. 1996. Nitric oxide synthase activities in human myometrium and villous trophoblast throughout pregnancy. Obstet Gynecol 87:249–253.
Rees DD, Palmer RMJ, Schulz R, Hodson HF, & Moncada S. 1990. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol 101:146–152.
Roberts JM, Taylor RN, & Goldfien A. 1991. Clinical and biochemical evidence of endothelial cell dysfunction in the pregnancy syndrome preeclampsia. Am J Hypertens 4:700–708.
Rosenfeld CR, Killam AP, Battaglia FC, Makowski G, & Meschia G. 1973. Effect of estradiol-17ß on the magnitude and distribution of uterine blood flow in nonpregnant oophorectomized ewes. Pediatr Res 7:139–148.
Rosseli M, Imthurn B, Keller PJ, Jackson EK, & Dubey RK. 1995. Circulating nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17ß-estradiol and norethisterone acetate: a two year follow-up study. Hypertension 25 (Part 2):848–853.
Rutherford RA, McCarthy A, Sullivan MH, Elder MG, Polak JM, & Wharton J. 1995. Nitric oxide synthase in human placenta and umbilical cord from normal, intrauterine growth-retarded and pre-ec1amptic pregnancies. Br J Pharmacol 116:3099–3109.
Salhab W, Shaul P, Cox B, & Rosenfield CR. 1998. Daily estradiol-17ß increases nitric oxide synthesis (NOS) in uterine arteries of nonpregnant ewes. J Soc Gynecol Invest 5(1S):52A.
Sladek SM, Regenstein AC, Lykins D, & Roberts JM. 1993. Nitric oxide synthase activity in pregnant rabbit uterus decreases on the last day of pregnancy. Am J Obstet Gynecol 169:1285–1291.
Sladek SM, Kanbour-Shakir A, Watkins S, Berghorn KA, Hoffman GE, & Roberts JM. 1998. Granulated metrial gland cells contain nitric oxide synthases during pregnancy in the rat placenta. Placenta 19:55–65.
Sladek SM, & Roberts JM. 1996. Nitric oxide synthase activity in the gravid rat uterus decreases a day before the onset of parturition. Am J Obstet Gynecol 175:1661–1667.
Stampfer MJ, Colditz GA, Willett WC, Manson JE, Rosner B, Speizer FE, & Hennekens CH. 1991. Postmenopausal estrogen therapy and cardiovascular disease; ten-year follow-up from the nurses’ health study. N Engl J Med 325:156–162.
Tschugguel W, Schneeberger C, Zhegu Z, Wieser F, Waselmayr B, Sator MO, Wojita J, Binder BR, & Huber JC. 1998. Distinct expression pattern of estrogen receptor alpha and beta mRNA in cultured human endothelial and vascular smooth muscle cells. J Soc Gynecol Invest 5(1S):143.
Weiner CP, Knowles RG, Nelson SE, & Stegink LD. 1994. Pregnancy increases oxide synthesis. Endocrinology 135:2413–2418.
Wieczorek KM, Brewer AS, & Myatt L. 1995. Shear stress may stimulate release and action of nitric oxide in the human fetal-placental vasculature. Am J Obstet Gynecol 175:708–713.
Van Buren GA, Yang DA, & Clark KE. 1992. Estrogen-induced uterine vasodilation is antagonized by L-nitroarginine methyl ester, an inhibitor of nitric oxide synthesis. Am J Obstet Gynecol 167:828–833.
Veille JC, Li P, Eisenach JC, Massmann AG, & Figueroa JP. 1996. Effects of estrogen on nitric oxide biosynthesis and vasorelaxant activity in sheep uterine and renal arteries in vitro. Am J Obstet Gynecol 174:1043–1049.
Yallampalli C, & Garfield RE. 1993. Inhibition of nitric oxide synthesis in rats produces signs similar to those of preeclampsia. Am J Obstet Gynecol 169:1316–1320.
Yallampalli C, Garfield RE, & Byam-Smith M. 1993a. Nitric oxide inhibits uterine contractility during pregnancy but not during delivery. Endocrinology 133:1899–1902.
Yallampalli C, Byam-Smith M, Nelson SO, & Garfield RE. 1994b. Steroid hormones modulate the production of nitric oxide and cGMP in the rat uterus. Endocrinology 134:1971–1974.
Yallampalli C, Izumi H, Byam-Smith M, & Garfield RE: 1994a. An L-arginine-nitric oxide cyclic guanosine monophosphate system exists in the uterus and inhibits contractility during pregnancy. Am J Obstet Gynecol 170:175–185.
Yang DA, Lang U, Greenberg SG, Myatt L, & Clark KE. 1996. Elevation of nitrate levels in pregnant ewes and their fetuses. Am J Obstet Gynecol 174:573–577.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer Science+Business Media New York
About this chapter
Cite this chapter
Clark, K.E., Myatt, L. (2000). Uterine Effects of Nitric Oxide. In: Kadowitz, P.J., McNamara, D.B. (eds) Nitric Oxide and the Regulation of the Peripheral Circulation. Nitric Oxide in Biology and Medicine, vol 1. Birkhäuser, Boston, MA. https://doi.org/10.1007/978-1-4612-1326-0_17
Download citation
DOI: https://doi.org/10.1007/978-1-4612-1326-0_17
Publisher Name: Birkhäuser, Boston, MA
Print ISBN: 978-1-4612-7095-9
Online ISBN: 978-1-4612-1326-0
eBook Packages: Springer Book Archive